Skip to main content
Top
Published in: Journal of Natural Medicines 4/2009

01-10-2009 | Original Paper

Saponin fraction from Astragalus membranaceus roots protects mice against polymicrobial sepsis induced by cecal ligation and puncture by inhibiting inflammation and upregulating protein C pathway

Authors: Xing-hua Gao, Xian-xiang Xu, Rong Pan, Ying Li, Yu-bin Luo, Yu-feng Xia, Kazuya Murata, Hideaki Matsuda, Yue Dai

Published in: Journal of Natural Medicines | Issue 4/2009

Login to get access

Abstract

Sepsis remains the leading cause of death in intensive care units. Uncontrolled systemic inflammation and an impaired protein C pathway are two important contributors to sepsis pathophysiology. Based on the beneficial effects of the saponin fraction from Astragalus membranaceus roots (SAM) against inflammation, liver dysfunction, and endothelium injury, we investigated the potential protective roles and underlying mechanisms of SAM on polymicrobial sepsis induced by cecal ligation and puncture (CLP) in mice. SAM, orally administered 1 h before and after CLP, significantly elevated the survival rate of mice. At 96 h after CLP operation, all mice in the model group died, whereas 33.3% of mice in the SAM (400 mg/kg)-treated group survived. SAM attenuated both inflammatory factors and their abilities to induce tissue dysfunction, which was mainly evidenced by decreased infiltration of polymorphonuclear leukocytes, tissue edema, and lung wet-to-dry weight ratio, lowered levels of myeloperoxidase (MPO), nitric oxide (NO), lactate dehydrogenase (LDH), alanine aminotransferase (ALT), and aspartate aminotransferase (AST) in serum, as well as downregulated expressions of iNOS and IL-1β mRNA in livers. Furthermore, we addressed the effects of SAM on the protein C (PC) pathway, closely linked with sepsis. In CLP-induced septic mice, SAM elevated the impaired expression of PC mRNA in livers. In vitro, SAM reversed the decreased expressions of thrombomodulin (TM) and endothelial PC receptor (EPCR) mRNA induced by lipopolysaccharide (LPS) in endothelial cells. These findings suggest that SAM is able to restore the impaired protein C pathway. Taken together, the current study demonstrates that SAM has protective effects on polymicrobial sepsis in mice. The mechanisms of action involve anti-inflammation and upregulation of the PC pathway.
Literature
1.
go back to reference Martin GS, Mannino DM, Eaton S, Moss M (2003) The epidemiology of sepsis in the United States from 1979 through 2000. Engl J Med 348:1546–1554CrossRef Martin GS, Mannino DM, Eaton S, Moss M (2003) The epidemiology of sepsis in the United States from 1979 through 2000. Engl J Med 348:1546–1554CrossRef
2.
go back to reference Seam N, Suffredini AF (2007) Mechanisms of sepsis and insights from clinical trials. Drug Discov Today Dis Mech 4:83–93PubMedCrossRef Seam N, Suffredini AF (2007) Mechanisms of sepsis and insights from clinical trials. Drug Discov Today Dis Mech 4:83–93PubMedCrossRef
3.
go back to reference Aird WC (2003) The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome. Blood 101:3765–3777PubMedCrossRef Aird WC (2003) The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome. Blood 101:3765–3777PubMedCrossRef
4.
go back to reference Esmon CT (2005) The interactions between inflammation and coagulation. Br J Haemat 131:417–430CrossRef Esmon CT (2005) The interactions between inflammation and coagulation. Br J Haemat 131:417–430CrossRef
5.
go back to reference Daniel G, Remick MD (2007) Pathophysiology of sepsis. Am J Pathol 170:1435–1444CrossRef Daniel G, Remick MD (2007) Pathophysiology of sepsis. Am J Pathol 170:1435–1444CrossRef
6.
go back to reference Dhainaut JF, Marin N, Mignon A, Vinsonneau C (2001) Hepatic response to sepsis: interaction between coagulation and inflammatory processes. Critical Care Med 29:S42–S47CrossRef Dhainaut JF, Marin N, Mignon A, Vinsonneau C (2001) Hepatic response to sepsis: interaction between coagulation and inflammatory processes. Critical Care Med 29:S42–S47CrossRef
7.
go back to reference Yan SB, Helterbrand JD, Hartman DL, Wright TJ, Bernard GR (2001) Low levels of protein C are associated with poor outcome in severe sepsis. Chest 120:915–922PubMedCrossRef Yan SB, Helterbrand JD, Hartman DL, Wright TJ, Bernard GR (2001) Low levels of protein C are associated with poor outcome in severe sepsis. Chest 120:915–922PubMedCrossRef
9.
go back to reference Eichacker PQ, Natanson C (2007) Increasing evidence that the risks of rhAPC may outweigh its benefits. Intensive Care Med 33:396–399PubMedCrossRef Eichacker PQ, Natanson C (2007) Increasing evidence that the risks of rhAPC may outweigh its benefits. Intensive Care Med 33:396–399PubMedCrossRef
10.
go back to reference Jin R, Kurashige S (1996) Effect of shi-ka-ron on cytokine production of lymphocytes in mice treated with cyclophosphamide. Am J Chinese Med 24:37–44CrossRef Jin R, Kurashige S (1996) Effect of shi-ka-ron on cytokine production of lymphocytes in mice treated with cyclophosphamide. Am J Chinese Med 24:37–44CrossRef
11.
go back to reference Li HB, Ge YK, Zhang L, Zheng XX (2006) Astragaloside IV improved barrier dysfunction induced by acute high glucose in human umbilical vein endothelial cells. Life Sci 79:1186–1193PubMedCrossRef Li HB, Ge YK, Zhang L, Zheng XX (2006) Astragaloside IV improved barrier dysfunction induced by acute high glucose in human umbilical vein endothelial cells. Life Sci 79:1186–1193PubMedCrossRef
12.
go back to reference Cui R, He J, Wang B, Zhang F, Chen G, Yin S, Shen H (2003) Suppressive effect of Astragalus membranaceus Bunge on chemical hepatocarcinogenesis in rats. Cancer Chemother Pharmacol 51:75–80PubMedCrossRef Cui R, He J, Wang B, Zhang F, Chen G, Yin S, Shen H (2003) Suppressive effect of Astragalus membranaceus Bunge on chemical hepatocarcinogenesis in rats. Cancer Chemother Pharmacol 51:75–80PubMedCrossRef
13.
go back to reference Minsook R, Eun HK, Mison C (2008) Astragali Radix elicits anti-inflammation via activation of MKP-1, concomitant with attenuation of p38 and Erk. J Ethnopharm 115:184–193CrossRef Minsook R, Eun HK, Mison C (2008) Astragali Radix elicits anti-inflammation via activation of MKP-1, concomitant with attenuation of p38 and Erk. J Ethnopharm 115:184–193CrossRef
14.
go back to reference Zhang WJ, Hufnagl P, Binder BR, Wojta J (2003) Antiinflammatory activity of astragaloside IV is mediated by inhibition of NF-κB activation and adhesion molecule expression. Thromb Haemost 90:904–914PubMed Zhang WJ, Hufnagl P, Binder BR, Wojta J (2003) Antiinflammatory activity of astragaloside IV is mediated by inhibition of NF-κB activation and adhesion molecule expression. Thromb Haemost 90:904–914PubMed
15.
go back to reference Wichterman KA, Baue AE, Chaudry IH (1980) Sepsis and septic shock—a review of laboratory models and a proposal. J Surg Res 29:189–201PubMedCrossRef Wichterman KA, Baue AE, Chaudry IH (1980) Sepsis and septic shock—a review of laboratory models and a proposal. J Surg Res 29:189–201PubMedCrossRef
16.
go back to reference Ma XQ, Shi Q, Duan JA, Dong TTX, Tsim KWK (2002) Chemical analysis of Radix Astragali (Huangqi) in China: a comparison with its adulterants and seasonal variations. J Agric Food Chem 50:4861–4866PubMedCrossRef Ma XQ, Shi Q, Duan JA, Dong TTX, Tsim KWK (2002) Chemical analysis of Radix Astragali (Huangqi) in China: a comparison with its adulterants and seasonal variations. J Agric Food Chem 50:4861–4866PubMedCrossRef
17.
go back to reference Huang CR, Wang GJ, Li H, Xie HT, Sun JG, Lv H, Lv T (2006) Sensitive and selective liquid chromatography–electrospray ionization–mass spectrometry analysis of astragaloside-IV in rat plasma. J Pharm Biomed Anal 40:788–793PubMedCrossRef Huang CR, Wang GJ, Li H, Xie HT, Sun JG, Lv H, Lv T (2006) Sensitive and selective liquid chromatography–electrospray ionization–mass spectrometry analysis of astragaloside-IV in rat plasma. J Pharm Biomed Anal 40:788–793PubMedCrossRef
18.
go back to reference Wang SG, Li JY, Huang H, Gao W, Zhuang CL, Li B, Zhou P, Kong DY (2009) Anti-hepatitis B virus activities of astragaloside IV isolated from Radix Astragali. Biol Pharm Bull 32:132–135PubMedCrossRef Wang SG, Li JY, Huang H, Gao W, Zhuang CL, Li B, Zhou P, Kong DY (2009) Anti-hepatitis B virus activities of astragaloside IV isolated from Radix Astragali. Biol Pharm Bull 32:132–135PubMedCrossRef
19.
go back to reference Xu XX, Zhang R, Xia LZ (2008) Effects of three saponin extracting methods on content of astragaloside IV. Chin J Vet Drug 42:12–14 Xu XX, Zhang R, Xia LZ (2008) Effects of three saponin extracting methods on content of astragaloside IV. Chin J Vet Drug 42:12–14
20.
go back to reference Yang J, Dai Y, Xia YF (2009) Alpinia katsumadai Hayata prevents mouse sepsis induced by cecal ligation and puncture through promoting bacterial clearance and downregulating systemic inflammation. Phytother Res 23:267–273PubMedCrossRef Yang J, Dai Y, Xia YF (2009) Alpinia katsumadai Hayata prevents mouse sepsis induced by cecal ligation and puncture through promoting bacterial clearance and downregulating systemic inflammation. Phytother Res 23:267–273PubMedCrossRef
21.
go back to reference Hotchkiss KA, Ashton AW, Mahmood R, Russell RG, Sparano JA, Schwartz EL (2002) Inhibition of endothelial cell function in vitro and angiogenesis in vivo by docetaxel (Taxotere): association with impaired repositioning of the microtubule organizing center. Mol Cancer Ther 1:1191–1200PubMed Hotchkiss KA, Ashton AW, Mahmood R, Russell RG, Sparano JA, Schwartz EL (2002) Inhibition of endothelial cell function in vitro and angiogenesis in vivo by docetaxel (Taxotere): association with impaired repositioning of the microtubule organizing center. Mol Cancer Ther 1:1191–1200PubMed
22.
23.
go back to reference Bochud PY, Calandra T (2003) Pathogenesis of sepsis: new concepts and implications for future treatment. BMJ 326:262–266PubMedCrossRef Bochud PY, Calandra T (2003) Pathogenesis of sepsis: new concepts and implications for future treatment. BMJ 326:262–266PubMedCrossRef
24.
go back to reference Vincent JL, Zhang H, Szabo C, Preiser JC (2000) Effects of nitric oxide in septic shock. Am J Respir Crit Care Med 161:1781–1785PubMed Vincent JL, Zhang H, Szabo C, Preiser JC (2000) Effects of nitric oxide in septic shock. Am J Respir Crit Care Med 161:1781–1785PubMed
25.
go back to reference Bultinck J, Sips P, Vakaet L, Brouckaert P, Cauwels A (2006) Systemic NO production during (septic) shock depends on parenchymal and not on hematopoietic cells: in vivo iNOS expression pattern in (septic) shock. FASEB J 20:2363–2365PubMedCrossRef Bultinck J, Sips P, Vakaet L, Brouckaert P, Cauwels A (2006) Systemic NO production during (septic) shock depends on parenchymal and not on hematopoietic cells: in vivo iNOS expression pattern in (septic) shock. FASEB J 20:2363–2365PubMedCrossRef
26.
go back to reference Pinsky MR, Vincent JL, Deviere J, Alegre M, Kahn RJ, Dupont E (1993) Serum cytokine levels in human spetic shock: relation to multiple system organ failure and mortality. Chest 103:562–575CrossRef Pinsky MR, Vincent JL, Deviere J, Alegre M, Kahn RJ, Dupont E (1993) Serum cytokine levels in human spetic shock: relation to multiple system organ failure and mortality. Chest 103:562–575CrossRef
27.
go back to reference Fisher CJ, Yan SB (2000) Protein C levels as a prognostic indicator of outcome in sepsis and related diseases. Crit Care Med 28:S49PubMedCrossRef Fisher CJ, Yan SB (2000) Protein C levels as a prognostic indicator of outcome in sepsis and related diseases. Crit Care Med 28:S49PubMedCrossRef
28.
go back to reference Mesters RM, Helterbrand J, Utterback BG, Yan B, Chao YB, Fernandez JA, Griffin JH, Hartman DL (2000) Prognostic value of protein C concentrations in neutropenic patients at high risk of severe septic complications. Crit Care Med 28:2209PubMedCrossRef Mesters RM, Helterbrand J, Utterback BG, Yan B, Chao YB, Fernandez JA, Griffin JH, Hartman DL (2000) Prognostic value of protein C concentrations in neutropenic patients at high risk of severe septic complications. Crit Care Med 28:2209PubMedCrossRef
30.
31.
go back to reference Joyce DE, Grinnell BW (2002) Recombinant human activated protein C attenuates the inflammatory response in endothelium and monocytes by modulating nuclear factor-kappaB. Crit Care Med 30:S288–S293PubMedCrossRef Joyce DE, Grinnell BW (2002) Recombinant human activated protein C attenuates the inflammatory response in endothelium and monocytes by modulating nuclear factor-kappaB. Crit Care Med 30:S288–S293PubMedCrossRef
32.
go back to reference Joyce DE, Gelbert L, Ciaccia A, DeHoff B, Grinnell BW (2001) Gene expression profile of antithrombotic protein C defines new mechanisms modulating inflammation and apoptosis. J Biol Chem 276:11199–11203PubMedCrossRef Joyce DE, Gelbert L, Ciaccia A, DeHoff B, Grinnell BW (2001) Gene expression profile of antithrombotic protein C defines new mechanisms modulating inflammation and apoptosis. J Biol Chem 276:11199–11203PubMedCrossRef
33.
go back to reference Riewald M, Petrovan R, Donner A, Mueller BM, Ruf W (2002) Activation of endothelial cell protease activated receptor 1 by the protein C pathway. Science 296:1880–1882PubMedCrossRef Riewald M, Petrovan R, Donner A, Mueller BM, Ruf W (2002) Activation of endothelial cell protease activated receptor 1 by the protein C pathway. Science 296:1880–1882PubMedCrossRef
Metadata
Title
Saponin fraction from Astragalus membranaceus roots protects mice against polymicrobial sepsis induced by cecal ligation and puncture by inhibiting inflammation and upregulating protein C pathway
Authors
Xing-hua Gao
Xian-xiang Xu
Rong Pan
Ying Li
Yu-bin Luo
Yu-feng Xia
Kazuya Murata
Hideaki Matsuda
Yue Dai
Publication date
01-10-2009
Publisher
Springer Japan
Published in
Journal of Natural Medicines / Issue 4/2009
Print ISSN: 1340-3443
Electronic ISSN: 1861-0293
DOI
https://doi.org/10.1007/s11418-009-0348-2

Other articles of this Issue 4/2009

Journal of Natural Medicines 4/2009 Go to the issue